1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. CanSino Biologics Inc.
  6. News
  7. Summary
    6185   CNE100003F01

CANSINO BIOLOGICS INC.

(6185)
  Report
Delayed Hong Kong Stock Exchange  -  05/27 04:08:54 am EDT
78.60 HKD   +8.86%
05/27Chinese Shares End Mixed; CanSino Rallies 18.5%, Visual China Tumbles 4.5%
MT
05/26Solution's Unit Inks MOU for Vaccine Development
MT
05/25Solution Biologics Sdn Bhd Signs Memorandum of Understanding with National Institutes of Biotechnology Malaysia and CanSino Biologics Inc
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Hong Kong shares close unchanged; Fed policy in focus

01/11/2022 | 04:05am EDT

Jan 11 (Reuters) - Hong Kong shares closed flat on Tuesday with gains in Wuxi Biologics and Tencent offset by losses in Alibaba and AIA Group, while investors kept an eye out for clues from the U.S. Federal Reserve about the timing of expected policy tightening.

** The Hang Seng index was unchanged at 23,739.06, while the China Enterprises index was unchanged at 8,369.01 points.

** "Hong Kong's equity market can still get worse before it gets better unless we see major changes in the current policy risk factors," Natixis analysts said in a note.

** Some of Wall Street's biggest banks now expect four U.S. interest rate increases this year starting in March, a more aggressive call than a week ago.

** In comments prepared for delivery at a congressional hearing later in the day, Fed Chair Jerome Powell pledged "to prevent higher inflation from becoming entrenched".

** The Hang Seng Tech index edged lower 0.1%, with Alibaba Group down 1.6%, while Tencent Holdings and Meituan finished up 1.5% and 0.7%, respectively

** Wuxi Biologics jumped 6% to become the biggest percentage gainer on the Hang Seng index, after a filing showed JPMorgan Chase & Co's long position in the pharmaceutical firm had risen to 5%.

** The Hang Seng healthcare sub-index gained 1.9%. CanSino Biologics Inc fell 5.5% on a share sale report.

** AIA Group finished down 1.8%. The insurer and Alibaba were the two biggest constituents weighing down the Hang Seng index.

** Property developer Shimao Group Holdings added 0.5% after it denied a report that it had entered into a preliminary agreement to sell a Shanghai plaza, but said it was in talks with potential buyers to sell some properties.

** Mainland real estate developers listed in Hong Kong rose 1.5%. (Reporting by the Shanghai Newsroom; Editing by Shounak Dasgupta)


© Reuters 2022
Stocks mentioned in the article
ChangeLast1st jan.
AIA GROUP LIMITED 2.86% 79.25 Delayed Quote.0.83%
AUSTRALIAN DOLLAR / US DOLLAR (AUD/USD) 0.87% 0.716 Delayed Quote.-2.23%
BRITISH POUND / US DOLLAR (GBP/USD) 0.09% 1.26275 Delayed Quote.-6.75%
CANADIAN DOLLAR / US DOLLAR (CAD/USD) 0.33% 0.7853 Delayed Quote.-1.03%
CANSINO BIOLOGICS INC. 8.86% 78.6 Delayed Quote.-56.38%
EURO / US DOLLAR (EUR/USD) -0.01% 1.07317 Delayed Quote.-5.61%
HANG SENG 2.89% 20697.36 Delayed Quote.-11.54%
INDIAN RUPEE / US DOLLAR (INR/USD) 0.05% 0.012892 Delayed Quote.-4.10%
MEITUAN INC. 3.34% 163.9 Delayed Quote.-27.28%
NEW ZEALAND DOLLAR / US DOLLAR (NZD/USD) 0.83% 0.6534 Delayed Quote.-5.22%
SHIMAO GROUP HOLDINGS LIMITED -2.21% 4.42 Delayed Quote.-13.33%
TENCENT HOLDINGS LIMITED 2.27% 341.8 Delayed Quote.-25.18%
WUXI BIOLOGICS (CAYMAN) INC. 7.21% 54.3 Delayed Quote.-41.33%
All news about CANSINO BIOLOGICS INC.
05/27Chinese Shares End Mixed; CanSino Rallies 18.5%, Visual China Tumbles 4.5%
MT
05/26Solution's Unit Inks MOU for Vaccine Development
MT
05/25Solution Biologics Sdn Bhd Signs Memorandum of Understanding with National Institutes o..
CI
05/23Chinese Shares End Muted; CanSino Falls Nearly 3% in Shanghai After WHO Approval
MT
05/22WHO Grants Emergency-Use Approval to CanSino's COVID-19 Vaccine
MT
05/20Hong Kong Stocks Jump to Two-Week High; CanSino Bio Surges 10%
MT
05/20WHO Grants Emergency Use Authorization to CanSino Bio's COVID Vaccine; Shares Rally 13%
MT
05/19CanSino Biologics Rises After WHO Approves Covid Vaccine for Emergency Use
DJ
05/19CanSinoBIO's COVID-19 Vaccine Convidecia™ Receives WHO Emergency Use Listing
AQ
05/19CanSinoBIO's COVID-19 Vaccine Convidecia™ Receives WHO Emergency Use Listing
CI
More news
Analyst Recommendations on CANSINO BIOLOGICS INC.
More recommendations
Financials
Sales 2022 2 711 M 405 M 405 M
Net income 2022 -34,6 M -5,17 M -5,17 M
Net cash 2022 4 125 M 616 M 616 M
P/E ratio 2022 59,6x
Yield 2022 0,11%
Capitalization 29 310 M 4 375 M 4 375 M
EV / Sales 2022 9,29x
EV / Sales 2023 9,05x
Nbr of Employees 1 946
Free-Float 39,3%
Chart CANSINO BIOLOGICS INC.
Duration : Period :
CanSino Biologics Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CANSINO BIOLOGICS INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 67,08 CNY
Average target price 156,59 CNY
Spread / Average Target 133%
EPS Revisions
Managers and Directors
Xue Feng Yu Chairman, Chief Executive Officer & GM
Xi Luo Chief Financial Officer
Jiang Feng Li Chairman-Supervisory Board
Tao Zhu Executive Director, CSO & Deputy General Manager
Li Feng Xu SVP-Regulatory Affairs & Clinical Operation Center
Sector and Competitors
1st jan.Capi. (M$)
CANSINO BIOLOGICS INC.-56.38%4 375
CSL LIMITED-7.46%92 708
SAMSUNG BIOLOGICS CO.,LTD.-7.64%47 463
BIOGEN INC.-14.05%30 198
WUXI BIOLOGICS (CAYMAN) INC.-41.33%29 183
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.-32.02%20 229